US Patent Issued to Memorial Sloan Kettering Cancer Center on Oct. 14 for "CD33 antibodies and methods of using the same to treat cancer" (New York Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,793, issued on Oct. 14, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"CD33 antibodies and methods of using the same to treat cancer" was invented by Nai-Kong V. Cheung (New York), Sayed Shahabuddin Hoseini (New York) and Mahiuddin Ahmed (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to immunoglobulin-related compositions (e.g., antibodies or antigen binding fragments thereof) that can bind to the CDS 3 protein. The antibodies of the present technology are useful in methods for detecting and treating Alzheimer's disease or a CDS 3-associated cancer in a subject in need thereof."...